4 Pot Stocks Make it to TSX 30: 1 Lands on Top Spot

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC), Village Farms International Inc. (TSX:VFF)(NASDAQ:VFF), Aphria Inc. (TSX:APHA)(NYSE:APHA), and Neptune Wellness Solutions Inc. (TSX:NEPT)(NASDAQ:NEPT) belong to the Top 10 of the inaugural TSX 30 program.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The first-ever recognition program of the Toronto Stock Exchange that highlights the 30 top-performing Canadian stocks is a significant boost to the cannabis sector. The so-called TSX 30 lists four pot stocks among the top 10 and one cracks the top spot.

Canopy Growth (TSX:WEED)(NYSE:CGC) came in at number one, while Village Farms took the third spot. Aphria and Neptune Wellness are in sixth and eighth place, respectively. The list confirms the growth potential of pot stocks.

To each his own

The basis for the rankings is the three-year return. With Canopy’s +1,823%, the early mover in the Canadian cannabis market gets the top spot. The TSX recognizes Canopy Growth as a multi-faceted cannabis producer with a strong investment in brand, market, and product differentiation.

Despite its recent struggles, Canopy remains the dominant cannabis company. The partnership with Constellation Brands assures the company of a global business that can potentially generate a significant and sustained return on shareholder capital over the long term.

Village Farms’s three-year return of +868% is just 15% shy of second-place Shopify. Based on analysts’ forecasts, VFF could potentially gain by as much as 288% in the next 12 months. The current dip of the stock is an excellent buying opportunity.

Village Farms, the longest-operating vertically integrated greenhouse grower in North America, is set to capitalize on the lucrative hemp-derived CBD market. The company has agreements in place Canada’s two big provinces — Ontario and British Columbia — with branded cannabis products for the recreational market.

Aphria ranks sixth because of its +479% return for three years. This $1.68 billion company has built the foundation to become a global leader in the cannabis space. It has the cultivation, manufacturing, research, and distribution infrastructure. Besides, Aphria has strategic investments and alliances to scale globally.

At $6.70, the stock is trading at a bargain. For being the first major cannabis company to declare income and on the road to profitability, analysts are also projecting a capital gain of 288%. The company is gearing up for the legalization of Cannabis 2.0. The immediate plan is to expand the consumer base via the concentrates and vapes.

The three-year return of Neptune Wellness is 322%. This CBD extraction services provider seems ready for epic growth. The company was able to bag the biggest extraction deal ever. Neptune will extract CBD from 230,000 kg of cannabis and hemp biomass that The Green Organic Dutchman owns.

Another three-year extraction services agreement involving 125,000 kg from Tilray is in place. For the next three years, at least, Neptune’s cash flow is certain. Extraction services are in demand as more industry players prepare to launch CBD-infused products and other derivatives.

Eventual industry leader

In the near term, the legal cannabis market could be worth $15-$50 billion. But over the long term, the opportunity is in the vicinity of $250-$500 billion.

Of the four pot stocks, Canopy Growth would eventually be the industry leader. It has the war chest to make the necessary investments to scale up operations. As the cannabis market matures, expect Canopy would have the capital spending discipline to be self-sustaining.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of Shopify, Shopify, and Village Farms International, Inc. Shopify is a recommendation of Stock Advisor Canada.  Village Farms is a recommendation of Hidden Gems Canada.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »